top of page
背景画像.png

​COMPANY

Trade

aceRNA Technologies Co., Ltd.

CEO

Fumihiro Sugawa

External
Directors

Hirohide Saito (Professor at Kyoto University and the University of Tokyo)
Nobuhiro Yagi (Kyoto University Innovation Capital Co., Ltd.)
Mikihiko Shinozaki (Mitsubishi UFJ Capital Co., Ltd.)
Norihide Hayakawa (DCI Partners Co., Ltd.)
Makoto (Mark) Ohori (UTokyo Innovation Platform Co., Ltd.)

Establishment

April 2018

Mission

Corporate Vision

To eradicate untreatable diseases.
Contribute to Regenerative Medicine and Drug Development through the discovery of novel miRNA applications.

Capital

JPY 30,000,000

Number of Employees

13(As of the end of July 2025)

Address

Innovation Hub Kyoto, 46-29 Yoshidashimoadachi-cho, Sakyo-ku,
Kyoto 606-8304 JAPAN

Main Office

Tokyo Office

​#318 Bldg.South, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485 Japan

aceRNA Technologies Co., Ltd.

Innovation Hub Kyoto, 46-29
Yoshidashimoadachi-cho, Sakyo-ku, Kyoto 606-8304 JAPAN

Privacy Policy

©Copyright aceRNA Technologies. All Rights Reserved.

bottom of page